GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: P005672 | Seysara®
                                 
                                                         
                            
                            
                            
                                 
                                
                                sarecycline is an approved drug (FDA (2018)) 
                                                        
                                                    
                                Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: Sarecycline is a tetracycline antibacterial with narrow-spectrum activity that was developed as an oral anti-acne therapeutic. Note that the structure shown here matches the CAS-assigned structure and is the same as the ChEMBL entry linked to below. The PubChem standardized chemical structure (CID 54681908) for sarecycline is represented with slightly different stereochemistry.
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
| References | 
| 
                                                                         1. Deeks ED. (2019)
                                         Sarecycline: First Global Approval. Drugs, 79 (3): 325-329. [PMID:30659422]  | 
                                                                
| 
                                                                         2. Lomakin IB, Devarkar SC, Patel S, Grada A, Bunick CG. (2023)
                                         Sarecycline inhibits protein translation in Cutibacterium acnes 70S ribosome using a two-site mechanism. Nucleic Acids Res, 51 (6): 2915-2930. [PMID:36864821]  | 
                                                                
| 
                                                                         3. Zhanel G, Critchley I, Lin LY, Alvandi N. (2019)
                                         Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris. Antimicrob Agents Chemother, 63 (1). [PMID:30397052]  |